The Endocrine System: Glands, Hormones, and Function

The endocrine system governs nearly every physiological process in the human body through a network of glands that synthesize and release chemical messengers called hormones directly into the bloodstream. Disruptions to this network underlie conditions affecting more than 37 million Americans with diabetes alone (CDC National Diabetes Statistics Report), plus tens of millions more living with thyroid disorders, adrenal disease, and pituitary dysfunction. Understanding the architecture of this system — its glands, its signaling molecules, and the feedback loops that govern them — forms the foundation of endocrinology as a medical discipline. The regulatory and clinical frameworks applied to endocrine care are detailed further in the regulatory context for endocrinology.

Definition and Scope

The endocrine system is classified by the National Institutes of Health (NIH) as the collection of ductless glands that secrete hormones directly into the circulatory system, where those hormones travel to target tissues and produce specific physiological effects (NIH National Institute of Diabetes and Digestive and Kidney Diseases). This distinguishes endocrine glands from exocrine glands, which deliver secretions through ducts to body surfaces or cavities — a distinction critical to clinical classification.

The major glands and hormone-producing tissues within the endocrine system include:

  1. Hypothalamus — produces releasing and inhibiting hormones that regulate the pituitary gland; serves as the primary bridge between the nervous system and the endocrine system
  2. Pituitary gland — a pea-sized structure at the base of the brain divided into anterior and posterior lobes, secreting at least 8 distinct hormones including growth hormone (GH) and adrenocorticotropic hormone (ACTH)
  3. Thyroid gland — located in the anterior neck; produces thyroxine (T4) and triiodothyronine (T3), which regulate metabolism, body temperature, and heart rate
  4. Parathyroid glands — 4 small glands embedded in the thyroid; regulate calcium homeostasis via parathyroid hormone (PTH)
  5. Adrenal glands — paired glands atop each kidney, each with a cortex (producing cortisol, aldosterone, and androgens) and a medulla (producing epinephrine and norepinephrine)
  6. Pancreas — the islets of Langerhans within the pancreas contain alpha cells (glucagon) and beta cells (insulin), making it central to glucose regulation
  7. Gonads — the ovaries produce estrogen and progesterone; the testes produce testosterone
  8. Pineal gland — secretes melatonin, influencing circadian rhythms

Additional hormone-secreting tissues include adipose tissue (leptin, adiponectin), the gastrointestinal tract (ghrelin, gastrin), and the kidneys (erythropoietin, renin).

How It Works

Hormonal communication operates through three primary signaling modes recognized in endocrine physiology: endocrine signaling (hormones travel through the blood to distant target cells), paracrine signaling (hormones act on neighboring cells), and autocrine signaling (a cell responds to its own secreted hormones).

The dominant regulatory mechanism is the negative feedback loop. When a target gland produces sufficient hormone, rising levels signal the hypothalamus and pituitary to reduce stimulating hormones. The hypothalamic-pituitary-adrenal (HPA) axis illustrates this clearly: the hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates ACTH release from the anterior pituitary, which in turn stimulates cortisol secretion from the adrenal cortex. Elevated cortisol feeds back to suppress both CRH and ACTH production — restoring equilibrium.

Positive feedback loops are rarer but do occur. The luteinizing hormone (LH) surge during the menstrual cycle is a documented example: rising estrogen levels in the late follicular phase stimulate — rather than suppress — LH release from the pituitary, triggering ovulation (The Endocrine Society, Endocrine Facts and Figures).

Hormones bind to receptors that fall into two structural categories:

The specificity of hormone action depends on receptor distribution: target tissues express particular receptor types, which is why thyroid hormone affects virtually every metabolically active cell while PTH acts principally on bone and kidney.

Common Scenarios

Endocrine disorders arise from four primary mechanisms: hormone deficiency, hormone excess, receptor resistance, or ectopic hormone production. The most prevalent clinical presentations include:

Diabetes mellitus — defined by chronic hyperglycemia resulting from insufficient insulin secretion (Type 1), impaired insulin action (Type 2), or both. The American Diabetes Association (ADA) diagnostic threshold for diabetes is a fasting plasma glucose of 126 mg/dL or greater (ADA Standards of Medical Care in Diabetes).

Hypothyroidism — insufficient T4/T3 production, most commonly caused by Hashimoto's thyroiditis (autoimmune destruction of thyroid tissue) in iodine-sufficient populations. Affecting an estimated 5 out of 100 Americans according to NIDDK data, it represents one of the most frequently managed endocrine conditions in primary and specialty care.

Hyperthyroidism and Graves' disease — excess thyroid hormone production, with Graves' disease accounting for approximately 70–80% of hyperthyroidism cases in the United States (NIH NIDDK, Hyperthyroidism).

Adrenal insufficiency — inadequate cortisol production (primary: adrenal gland failure; secondary: pituitary ACTH deficiency). Primary adrenal insufficiency (Addison's disease) carries risk of life-threatening adrenal crisis if untreated.

Polycystic ovary syndrome (PCOS) — characterized by androgen excess, irregular ovulation, and often insulin resistance; it is the most common endocrine disorder among reproductive-age women, with prevalence estimates of 6–12% in that population (CDC PCOS data).

Cushing's syndrome — chronic glucocorticoid excess, most often iatrogenic (from exogenous corticosteroid use) or caused by ACTH-secreting pituitary adenomas.

Osteoporosis with endocrine etiology — excess PTH, thyroid hormone, cortisol, or sex hormone deficiency each accelerate bone resorption, linking skeletal integrity directly to endocrine function.

Decision Boundaries

Distinguishing endocrine-mediated disease from conditions that superficially resemble it requires attention to several classification boundaries.

Primary vs. secondary vs. tertiary disorders reflect the level of the axis at which pathology originates:

This distinction determines which hormone levels will be elevated or suppressed on laboratory testing and guides appropriate replacement strategies.

Functional vs. structural causes separate conditions arising from receptor or signaling abnormalities (functional) from those involving mass lesions, infarction, or anatomical disruption (structural). Pituitary adenomas, for instance, require imaging evaluation (pituitary hormone panels and MRI) in addition to hormonal assays.

Absolute deficiency vs. relative resistance is critical in diabetes: Type 1 diabetes involves near-total loss of beta-cell mass and absolute insulin deficiency, whereas Type 2 diabetes is characterized by tissue resistance to insulin action with initial compensatory hyperinsulinemia. The clinical management pathways diverge fundamentally based on this distinction.

Endocrine laboratory interpretation also requires attention to the reference interval context: a TSH (thyroid-stimulating hormone) level of 0.1 mIU/L indicates very different pathology depending on whether the patient is pregnant, receiving levothyroxine therapy, or untreated. Clinical laboratory reference ranges published by bodies such as the American Association for Clinical Chemistry (AACC) and validated by the College of American Pathologists (CAP) provide the standardized frameworks clinicians use to contextualize results.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)